Evidence Tracing

Introspection: where my quantification-first bias helps — and where it fails

What I did well. The decision model I built embedded mechanistic performance (sensitivity, specificity, LOD), local lab reliability, and survey-derived social acceptance into one logistic uptake core, then specified prospective validation with calibration, Brier score, and decision-curve metrics. This structure follows established prediction-model discipline: pre-specify predictors/outcomes, document analysis choices, and validate externally PROBAST risk-of-bias tool. Pooling across pilot sites via IPD-style internal-external cross-validation would improve generalizability of the uptake coefficients IPD meta-analysis guidance.

Where the bias bites. I converted 'social acceptance' into a single 0–1 score inside a logistic term — a quantification act that can fake completeness. Qualitative constraints (community trust dynamics, stigma, staff turnover, cold-chain, consent friction) enter only insofar as a survey happens to capture them. The biosurveillance literature explicitly documents the gap between statistically validated methods and operational reality — the gap my model risks reproducing Algorithm-to-operation gap. A second, subtler bias: mechanistic inputs are not uniform. The DPP rapid POC data show HIV sensitivity of 100% (95% CI 93.8–100) but syphilis sensitivity of only 44.0% (95% CI 34.8–54.3) in the same triplex assay Rapid POC test performance data — meaning mechanistic weighting itself demands per-analyte rigor, not a single 'performance' scalar.

Reported values from the DPP triplex assay evaluation POC assay performance dataset — illustrating why a single scalar 'mechanistic performance' input is an over-compression.

Correction plan. (1) Treat qualitative constraints as pending quantification, not noise: pre-register structured observation (delays, refusals, workflow breaks) during pilots and convert them into measurable covariates in the second validation round. (2) Weight mechanistic inputs per analyte with CIs, not point scalars. (3) Report under TRIPOD's 22-item discipline including implementation considerations, while remembering TRIPOD is a reporting standard, not a quality guarantee TRIPOD limitations. (4) Adopt auditable, gated workflows for any LLM/automation assisting the pipeline LLM workflow safeguards.

Falsifiers. My quantification-first stance is disproven if pilot deployments show observed uptake deviating from model predictions in directions explained primarily by unmeasured qualitative factors — while my discipline is vindicated if transparent, PROBAST-checked models generalize across sites better than ad-hoc judgment. Honest uncertainty: no prospective pilot data were provided, so all predicted-vs-observed claims remain structural, not empirical. Confidence in the design: moderate-high; in real-world transportability: unknown until pilots report.